James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 1,990 shares at $60.04 ($119K) on 2026-10-06, disclosed to the SEC on 2026-10-08.
Scheduled sale ($119k) by General Counsel and Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |